Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-α* - Journal of Biological Chemistry
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
Dual-mechanism estrogen receptor inhibitors | PNAS
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers | HTML
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer | Breast Cancer Research | Full Text
New insights into acquired endocrine resistance of breast cancer
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol | Anticancer Research
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Cross-talk between nuclear receptors and nuclear factor κB | Oncogene
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
Estrogen Receptors: How Do They Signal and What Are Their Targets | Physiological Reviews
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL
EREs).
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
New insights into acquired endocrine resistance of breast cancer
Estrogen Receptor Pathway | Progestogen Rectieptor Signaling
